These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3915956)

  • 1. Progressive dialytic encephalopathy and the problem of aluminum neurotoxicity.
    Bugiani O; Brancaccio D; Ghetti B
    Clin Nephrol; 1985; 24 Suppl 1():S20-5. PubMed ID: 3915956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialysis encephalopathy.
    Alfrey AC
    Clin Nephrol; 1985; 24 Suppl 1():S15-9. PubMed ID: 3915955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of dialysis encephalopathy in the context of rubidium and aluminum levels in the blood and cerebral cortex of patients with concomitant uremic polyneuropathy on long-term dialysis].
    Adamiec R; Uzar J
    Przegl Lek; 1987; 44(3):309-14. PubMed ID: 3615935
    [No Abstract]   [Full Text] [Related]  

  • 4. The dialysis encephalopathy syndrome. Possible aluminum intoxication.
    Alfrey AC; LeGendre GR; Kaehny WD
    N Engl J Med; 1976 Jan; 294(4):184-8. PubMed ID: 1244532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aluminum neurotoxicity].
    Langauer-Lewowicka H
    Neurol Neurochir Pol; 1994; 28(2):221-6. PubMed ID: 7913990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminum neurotoxicity and Alzheimer's disease.
    Still CN
    J S C Med Assoc; 1994 Nov; 90(11):560-4. PubMed ID: 7853860
    [No Abstract]   [Full Text] [Related]  

  • 7. Aluminum in tissues.
    Van de Vyver FL; De Broe ME
    Clin Nephrol; 1985; 24 Suppl 1():S37-57. PubMed ID: 3915959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The natural history of dialysis encephalopathy (author's transl)].
    Pogglitsch H; Wawschinek O; Holzer H; Petek W; Ladurner G; Katschnig H; Korthals C
    Acta Med Austriaca; 1980; 7(3):71-6. PubMed ID: 7223340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progressive dialytic encephalopathy].
    Rabey JM; Blum M; Vardi J; Aviram A; Moriel EZ; Streifler M
    Harefuah; 1980 Mar; 98(5):205-7. PubMed ID: 7409633
    [No Abstract]   [Full Text] [Related]  

  • 11. Progressive dialysis encephalopathy. Role of aluminum toxicity.
    Poisson M; Mashaly R; Lafforgue B
    Ann Neurol; 1979 Jul; 6(1):88. PubMed ID: 507770
    [No Abstract]   [Full Text] [Related]  

  • 12. Aspects of aluminum toxicity.
    Hewitt CD; Savory J; Wills MR
    Clin Lab Med; 1990 Jun; 10(2):403-22. PubMed ID: 2197055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progressive myoclonic encephalopathy in dialysis patients: presence of high concentrations of aluminium in the lysosomes of the cerebral cells (author's transl)].
    Galle P; Chatel M; Berry JP; Menault F
    Nouv Presse Med; 1979 Dec; 8(50):4091-4. PubMed ID: 530824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progressive dialytic encephalopathy. Role of the aluminium and neurological study. One case (author's transl)].
    Buge A; Escourolle R; Poisson M; Gray F; Bleibel JM; Jaudon MC
    Nouv Presse Med; 1979 Mar; 8(13):1071-4. PubMed ID: 461135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversible dialytic encephalopathy after interruption of aluminium intake. 6 cases (author's transl)].
    Buge A; Poisson M; Masson S; Bleibel JM; Mashaly R; Jaudon MC; Lafforgue B; Lebkiri B; Raymond P
    Nouv Presse Med; 1979 Sep; 8(34):2729-33. PubMed ID: 493078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialysis encephalopathy associated with polyvalent ion contamination.
    Hocken AG
    N Z Med J; 1984 Mar; 97(752):190-2. PubMed ID: 6583579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic encephalopathy as a complication of renal failure: mechanisms and mediators.
    Fraser CL; Arieff AI
    New Horiz; 1994 Nov; 2(4):518-26. PubMed ID: 7804801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminium neurotoxicity.
    van der Voet GB; Marani E; Tio S; de Wolff FA
    Prog Histochem Cytochem; 1991; 23(1-4):235-42. PubMed ID: 1947146
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serum aluminum in hemodialysis patients. Relation to osteodystrophy, encephalopathy and aluminum hydroxide consumption].
    Nielsen LP; Heaf JG
    Ugeskr Laeger; 1983 May; 145(18):1363-7. PubMed ID: 6868163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progressive encephalopathy in dialyzed patients].
    Masbernard A; Piette JC; Giudicelli CP; Lafforgue B; Beaulaton A; Jaudon MC
    Nouv Presse Med; 1977 Jun; 6(24):2172. PubMed ID: 905140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.